Logo

PTNM

Pitanium Limited

PTNM

Pitanium Limited • NASDAQ
$10.39 ▼ -14.27% (-1.73)
Market Cap $218.21 M
52w High $14.79
52w Low $0.98
Dividend Yield 0%
P/E 346.33
Volume 1.49M
Outstanding Shares 21.00M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q2-2025 $18.18M $16.515M $-351.616K -1.934% $-0.017 $-145.987K
Q1-2025 $18.18M ▲ $16.515M ▲ $-351.616K ▼ -1.934% ▼ $-0.017 ▼ $-145.987K ▼
Q2-2024 $17.937M $12.381M ▲ $1.551M 8.648% $0.074 $2.42M ▼
Q1-2024 $17.937M $12.381M $1.551M 8.648% $0.074 $2.42M

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q2-2025 $1.508M ▼ $4.5M ▼ $3.081M ▼ $1.419M ▼
Q1-2025 $1.51M ▼ $4.508M ▲ $3.087M ▲ $1.422M ▲
Q1-2024 $2.43M $0 $-1.301M $1.301M

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q2-2025 $-45.188K ▲ $-249.806K ▲ $-72.496K ▲ $-27.313K ▲ $0 $-367.283K ▲
Q1-2025 $-45.272K ▼ $-250.271K ▼ $-72.631K ▼ $-27.364K ▼ $0 ▼ $-367.966K ▼
Q2-2024 $198.22K ▼ $352.213K ▼ $19.906K ▼ $78.479K ▼ $3.326M ▲ $330.653K ▼
Q1-2024 $198.65K $352.977K $19.949K $78.649K $0 $331.37K

Five-Year Company Overview

Income Statement

Income Statement Pitanium’s income statement shows a very small but profitable business with fairly steady performance over the last two years. Revenue has been flat, which suggests the company is not yet in a clear growth phase. Profit margins look reasonable for such a small scale, but earnings per share slipped, hinting at either higher costs, share count changes, or early growth investments starting to weigh on the bottom line. Overall, it looks like a tiny, still‑experimental operation that has proven it can make money, but not yet that it can grow meaningfully.

Balance Sheet

Balance Sheet The balance sheet is simple and small. Cash and total debt are roughly in balance, so leverage does not appear extreme, but there is no large cash cushion either. Assets and equity are largely unchanged over the two years shown, reinforcing the picture of a company that has not yet scaled up or invested heavily in physical infrastructure. This light balance sheet can be flexible, but it also means limited resources if the business hits turbulence or needs to fund significant expansion from its own pocket.

Cash Flow

Cash Flow Cash flow is close to break‑even. Operating cash flow slipped from slightly positive to roughly flat, pointing to a business that covers its day‑to‑day needs but does not yet generate strong surplus cash. Capital spending is minimal, so free cash flow closely tracks operating cash flow. This “just breaking even” cash profile fits an early‑stage consumer brand: manageable in the short term, but any serious growth or international push will likely require either improved internal cash generation or external funding.

Competitive Edge

Competitive Edge Pitanium operates in a very crowded beauty and personal care market, where brand, speed, and marketing matter more than hard assets. Its main strengths are fast product launches, a mix of premium and mass‑market brands, and an omnichannel presence in Hong Kong. These help it react quickly to trends and reach a broad set of customers. However, the company is still small, with limited geographic reach and heavy competition from global and regional brands with deeper pockets. The recent trading halt and regulatory scrutiny in the U.S. also add a reputational and financing overhang that could weaken its standing with partners, suppliers, and potential international distributors until resolved.

Innovation and R&D

Innovation and R&D Innovation at Pitanium is centered on rapid product development, frequent new launches, and the use of contract manufacturers and outside technologies such as nano‑emulsions and stem‑cell‑based ingredients. This model keeps internal R&D light and flexible, but it can blur how much of the technology is truly proprietary versus sourced from partners. The pipeline includes a planned mobile app, new at‑home treatment lines, and ambitions for overseas expansion. The big questions are whether the company can turn fast innovation into lasting brand loyalty, maintain product quality and regulatory compliance, and differentiate its science‑based claims in a segment where many rivals also market “advanced” formulas.

Summary

Pitanium is effectively a small, niche beauty company that has proven it can operate profitably on a modest scale, with a lean balance sheet and near break‑even cash flows. Its story is built around speed, brand positioning, and at‑home professional treatments rather than heavy manufacturing or deep in‑house research. The upside case depends on turning that agility into sustained brand strength and international growth. The risk side includes flat revenue so far, limited financial resources, intense competition, and the serious uncertainty created by the SEC‑related trading halt, which raises governance and regulatory questions that sit above the basic business fundamentals. Overall, it looks like an early‑stage consumer brand with meaningful execution and regulatory risks alongside its innovation‑driven ambitions.